A Phase I Study of Systemic Gene Therapy with SGT-94 in Patients with Solid Tumors.
Phase of Trial: Phase I
Latest Information Update: 28 Apr 2017
At a glance
- Drugs SGT-94 (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 24 Apr 2017 Status changed from active, no longer recruiting to completed.
- 14 Sep 2016 Planned End Date changed from 1 Jan 2014 to 1 Jan 2016.
- 14 Sep 2016 Planned primary completion date changed from 1 Dec 2014 to 1 Dec 2016.